Healthcare
13 companies · Q1FY27
Read 6.4ConcallScore 7.4Trailing 7.2Growth 6.5Valuation 2.7
rating label | latest | 4Q avg | forward | higher = cheaper | the three, combined | ||
|---|---|---|---|---|---|---|---|
| 1 | Hospital | Narrow MoatMid | 7.6Bullish | 8.0Bullish | 7.1Solid | 6.2Undervalued | 7.3Aligned & cheap |
| 2 | Pharmaceuticals | Narrow MoatWeak | 7.7Bullish | 7.6Bullish | 7.6Strong | 3.8Expensive | 7.2Priced for it |
| 3 | Contract Research & Manufacturing (CRO/CDMO) | Narrow MoatMid | 7.3Bullish | 7.7Bullish | 6.1Moderate | — | 6.6No price read |
| 4 | Pharmaceuticals | Narrow MoatStrong | 8.1Strongly Bullish | 7.8Bullish | 7.1Solid | 0.6Richly priced | 6.6Priced for it |
| 5 | Pharmaceuticals | Narrow MoatWeak | 7.1Bullish | 7.3Bullish | 7.2Strong | 1.6Richly priced | 6.6Priced for it |
| 6 | Pharmaceuticals | Narrow MoatMid | 7.8Bullish | 7.1Bullish | 6.3Moderate | 3.4Expensive | 6.4Priced ahead of it |
| 7 | Pharmaceuticals | Narrow MoatWeak | 7.9Bullish | 7.3Bullish | 6.7Solid | 1.0Richly priced | 6.3Priced for it |
| 8 | Pharmaceuticals | Narrow MoatMid | 7.8Bullish | 7.3Bullish | 6.1Moderate | 2.5Expensive | 6.2Priced ahead of it |
| 9 | Pharmaceuticals | Narrow MoatMid | 7.5Bullish | 7.2Bullish | 6.0Moderate | 2.6Expensive | 6.1Priced ahead of it |
| 10 | Pharmaceuticals | — | 6.7Mildly Bullish | 6.5Mildly Bullish | 6.7Solid | 2.5Expensive | 6.1Priced ahead of it |
| 11 | Healthcare Research, Analytics & Technology | Narrow MoatWeak | 6.4Neutral / Balanced | 6.8Mildly Bullish | 6.4Moderate | 2.1Expensive | 6.0Priced ahead of it |
| 12 | Pharmaceuticals | No MoatWeak | 6.9Mildly Bullish | 6.7Mildly Bullish | 5.2Soft | 5.7Fair | 5.9Balanced |
| 13 | Pharmaceuticals | Narrow MoatWeak | — | 6.6Mildly Bullish | 6.6Solid | 0.9Richly priced | 5.8Outlook-led |